Business Daily.
.
A+ R A-
NEW YORK, Oct. 8, 2013 /PRNewswire/ -- Intercept Pharmaceuticals, Inc.  (NASDAQ: ICPT), a clinical stage biopharmaceutical company focused on the development and commercialization of novel bile acid therapeutics to treat chronic liver diseases, today announced the pricing of an......

Page 1090 of 2067

Grow Your Business with Times Media
Business Daily Media